Stockreport

Bayer Accelerates Pharma Growth on High-Value Portfolio

BAYER AG S/ADR  (BAYRY) 
NASDAQ:AMEX Investor Relations: investor.bayer.com
PDF Bayer is successfully executing on an ambitious growth strategyFive pivotal approvals worldwide in 2025 underscore a landmark year of strategic executionBayer will drive [Read more]